News

100 days into the job, FDA head talks to CNN about agency goals— and Coke’s switch to sugar
Commissioner Marty Makary says the FDA will plow ahead with big plans on ultra process foods, dietary guidelines and ...
Richmond Times-Dispatch14h
Virginia's HIV/AIDS patients to lose services because of federal cuts
A sharp drop in funds from the federal program to help people with HIV/AIDS means the state is dropping key services for ...
Opinion
Science-Based Medicine18hOpinion
FDA Has Replaced its Leadership With Doctors Who Have Done Their “Research”
A large tertiary care center in Sydney, Australia is pulling out all the stops to try and cut their expenses. As of next month, all doctors and nurses currently on staff will be replaced by parents ...
CBS Chicago on MSN1d
FDA's AI tool cites nonexistent study
The Trump administration has touted AI as a way to cut government staffing, but the FDA's new AI tool has been citing nonexistent studies.
Dermatology Advisor1d
Thousands Laid off From NIH, FDA and CDC After Supreme Court Decision
Last Monday, the U.S. Department of Health and Human Services (HHS) finalized 10,000 layoffs across federal health agencies, including the National Institutes of Health (NIH), U.S. Food and Drug ...
Forensic crime labs are buckling as new technology increases demand
Across the country, state and local crime labs are drowning in evidence. From rape kits to drug samples to vials of blood, ...
STAT2d
FDA’s new top drug regulator hails from industry
This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...
Government’s H.R. Arm Shedding a Third of Staff
More than 750 workers have resigned with incentives, and more than 150 others have resigned without. The agency has also laid ...
STAT3d
New head of FDA drug center is a biotech veteran and an outspoken critic of the academic establishment
“Dr. Tidmarsh is an accomplished physician-scientist and leader whose experience spans the full arc of drug development — ...
FDA appoints biotech veteran George Tidmarsh to lead drug evaluation division
Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...
FDA appoints biotech executive as top drug regulator under RFK Jr.
Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the agency’s ...
KFF Health News3d
NIH, FDA Cuts Would Lead To Fewer New Meds, CBO Analysis Indicates
An estimated 53 drugs would not enter the market in the next 30 years if the NIH is hit with a permanent 10% budget cut and the FDA experiences a nine-month drug review delay due to staffing cuts, the ...